|
VTA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.419940E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.167200E-04 |
| Normal-vs-Stage2 |
2.426000E-02 |
| Normal-vs-Stage3 |
7.505000E-01 |
| Normal-vs-Stage4 |
5.363200E-01 |
| Stage1-vs-Stage2 |
9.103600E-01 |
| Stage1-vs-Stage3 |
1.326050E-01 |
| Stage1-vs-Stage4 |
5.208400E-01 |
| Stage2-vs-Stage3 |
2.544600E-01 |
| Stage2-vs-Stage4 |
5.254800E-01 |
| Stage3-vs-Stage4 |
7.704000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.199600E-03 |
| Normal-vs-AfricanAmerican |
2.454300E-02 |
| Normal-vs-Asian |
2.238400E-01 |
| Caucasian-vs-AfricanAmerican |
8.266800E-01 |
| Caucasian-vs-Asian |
8.385800E-01 |
| AfricanAmerican-vs-Asian |
7.422200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.199600E-04 |
| Normal-vs-Female |
4.237200E-01 |
| Male-vs-Female |
4.778200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.136600E-03 |
| Normal-vs-Extreme_Weight |
4.17860000001546E-06 |
| Normal-vs-Obese |
1.752620E-01 |
| Normal-vs-Extreme_Obese |
3.058800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.383400E-01 |
| Normal_Weight-vs-Obese |
1.286450E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.361400E-01 |
| Extreme_Weight-vs-Obese |
2.065900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.390200E-01 |
| Obese-vs-Extreme_Obese |
6.762400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.671200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.168000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.626200E-04 |
| Normal-vs-Age(81-100Yrs) |
4.56199999998574E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.653600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.192350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.176100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.624360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.887800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.916400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.639800E-03 |
| Normal-VS-Type2 PRCC |
4.515300E-03 |
| Normal-VS-KIRP CIMP |
9.304300E-02 |
| Normal-VS-Unclassified PRCC |
6.400500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.664800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.199860E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.725200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.723080E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.265600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.459400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.358500E-04 |
| Normal-vs-N1 |
1.277980E-01 |
| Normal-vs-N2 |
1.40459999997677E-06 |
| N0-vs-N1 |
1.423060E-03 |
| N0-vs-N2 |
1.518390E-01 |
| N1-vs-N2 |
1.769590E-02 |
|
|
